A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats

BACKGROUND: Non‐replicating respiratory syncytial virus (RSV) vaccine candidates could potentially prime for enhanced respiratory disease (ERD) due to a T‐cell‐mediated immunopathology, following RSV infection. Vaccines with built‐in immune response modifiers, such as Toll‐like receptor (TLR) ligand...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Influenza Other Respir Viruses
Autors principals: Kamphuis, Tobias, Stegmann, Toon, Meijerhof, Tjarko, Wilschut, Jan, de Haan, Aalzen
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Part 3
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634254/
https://ncbi.nlm.nih.gov/pubmed/23575113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/irv.12112
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars